{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:27:49Z","timestamp":1786969669354,"version":"build-2736575974"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>This study examines the economic costs of radiotherapy equipment, linear accelerator (LINAC), Cobalt-60 teletherapy unit, and high-dose-rate (HDR) brachytherapy across secondary and tertiary public healthcare facilities in Tamil Nadu. The objective was to evaluate per-procedure costs from both health system and societal perspectives to determine financial sustainability and the impact of patient throughput on resource utilization.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>The study was conducted from February to September 2023, using cross-sectional patient surveys and retrospective record reviews in facilities with radiotherapy services. Costs including capital, maintenance, human resources, electricity, and out-of-pocket expenses were assessed from both health system and societal perspectives. Cost variations were analyzed by utilization levels, with validation through triangulation and sensitivity analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>During the inception year, per-procedure costs were highest for HDR brachytherapy due to low initial utilization (n = 253), while LINAC incurred the highest capital expenditure (Indian Rupees [INR] 170.8 million; $2.07 million). In the regular functioning phase, per-procedure costs declined substantially across all modalities as utilization increased. Cobalt-60 teletherapy unit demonstrated the lowest per-procedure cost (INR 7612), followed by HDR brachytherapy, whereas LINAC remained the most expensive modality from both health system and societal perspectives. These findings highlight the strong influence of utilization on cost efficiency.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Results indicated that higher patient utilization rates significantly reduce per-procedure costs across all equipment types, with LINAC having the highest per-procedure cost and HDR brachytherapy having the highest per-procedure cost during inception due to low throughput. Strategic recommendations, including public\u2013private partnerships, can enhance accessibility and ensure sustainable, equitable radiotherapy services across Tamil Nadu\u2019s healthcare system.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jcrt.jcrt_812_25","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T08:00:23Z","timestamp":1786780823000},"page":"531-539","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Cost analysis of radiotherapy equipment in public healthcare facilities of Tamil Nadu, South India"],"prefix":"10.4103","volume":"22","author":[{"given":"Yuvaraj","family":"Krishnamoorthy","sequence":"first","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India"},{"name":"Evidence Synthesis Unit, Partnerships for Research, Opportunities, Planning, Upskilling and Leadership (PROPUL) Evidence, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arivarasan","family":"Barathi","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhanajayan","family":"Govindan","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suthanthira","family":"Kannan","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deivasigamani","family":"Kuberan","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venmathi","family":"Elangovan","sequence":"additional","affiliation":[{"name":"Department of Community Medicine, ESIC Medical College and Hospital, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneera","family":"Parveen","sequence":"additional","affiliation":[{"name":"Partnership for Research, Opportunities, Planning, Upskilling, and Leadership (PROPUL) Evidence, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afrith John","family":"Poul","sequence":"additional","affiliation":[{"name":"Partnership for Research, Opportunities, Planning, Upskilling, and Leadership (PROPUL) Evidence, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Gilbert","family":"Majella","sequence":"additional","affiliation":[{"name":"Epidemiology and Public Health Unit, Partnership for Research, Opportunities, Planning, Upskilling, and Leadership (PROPUL) Evidence, Chennai, Tamil Nadu, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1177\/0972063421995025","article-title":"Emerging health technologies and how they can transform healthcare delivery","volume":"23","author":"Bhatia","year":"2021","journal-title":"J Health Manag"},{"key":"R2-20260817","first-page":"1","article-title":"From treatment to prevention: The evolution of digital healthcare","volume":"573","author":"Park","year":"2019","journal-title":"Nature"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2019.11456","article-title":"Trends in use of medical imaging in US health care systems and in Ontario, Canada, 2000-2016","volume":"322","author":"Smith-Bindman","year":"2019","journal-title":"JAMA"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/S1470-2045(15)00222-3","article-title":"Expanding global access to radiotherapy","volume":"16","author":"Atun","year":"2015","journal-title":"Lancet Oncol"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.mjafi.2014.10.004","article-title":"Life cycle costing as a decision making tool for technology acquisition in radio-diagnosis","volume":"71","author":"Chakravarty","year":"2015","journal-title":"Med J Armed Forces India"},{"key":"R7-20260817","first-page":"1","article-title":"Cancer control in low- and middle-income countries: Is it time to consider screening?","volume":"5","author":"Shah","year":"2019","journal-title":"J Glob Oncol"},{"key":"R8-20260817","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/1403494817715400","article-title":"The global cancer burden and human development: A review","volume":"46","author":"Fidler","year":"2018","journal-title":"Scand J Public Health"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1002\/ijc.33114","article-title":"Profiling global cancer incidence and mortality by socioeconomic development","volume":"147","author":"Lortet-Tieulent","year":"2020","journal-title":"Int J Cancer"},{"key":"R10-20260817","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1200\/GO.21.00029","article-title":"Global radiotherapy: Current status and future directions white paper","volume":"7","author":"Abdel-Wahab","year":"2021","journal-title":"JCO Glob Oncol"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"e33186","DOI":"10.1016\/j.heliyon.2024.e33186","article-title":"Exploring sustainable healthcare: Innovations in health economics, social policy, and management","volume":"10","author":"Hussain","year":"2024","journal-title":"Heliyon"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0970-0218.193344","article-title":"Towards a better health care delivery system: The Tamil Nadu model","volume":"41","author":"Parthasarathi","year":"2016","journal-title":"Indian J Community Med"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.orhc.2017.10.004","article-title":"Healthcare technology assessment under uncertainty: The case of digital medical linear accelerators","volume":"16","author":"Oliveira","year":"2018","journal-title":"Oper Res Health Care"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"e14246","DOI":"10.1002\/acm2.14246","article-title":"Linear accelerator maintenance cost analysis","volume":"25","author":"Carlone","year":"2024","journal-title":"J Appl Clin Med Phys"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jacr.2005.12.007","article-title":"Considerations of cost-effectiveness for new radiation oncology technologies","volume":"3","author":"Mills","year":"2006","journal-title":"J Am Coll Radiol"},{"key":"R17-20260817","article-title":"Health service resource use and costs of interventional oncology procedures: A micro-costing analysis","author":"Senanayake","journal-title":"OSF Preprints"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0167-8140(01)00467-4","article-title":"Maintenance costs for cobalt machines and linear accelerators: New machines versus old","volume":"62","author":"van der Giessen","year":"2002","journal-title":"Radiother Oncol"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"175","DOI":"10.11113\/jm.v46.459","article-title":"Evaluating the management and maintenance practices of linear accelerator and cobalt-60 cancer treatment machines in Nigeria: A comprehensive assessment","volume":"46","author":"Ilupeju","year":"2023","journal-title":"J Mekanikal"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semradonc.2019.08.007","article-title":"The cost-effectiveness and value proposition of brachytherapy","volume":"30","author":"Vu","year":"2020","journal-title":"Semin Radiat Oncol"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.brachy.2023.04.009","article-title":"Geographic and demographic distribution and access to brachytherapy in India with its implications on cancer care","volume":"22","author":"Krishna","year":"2023","journal-title":"Brachytherapy"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"288","DOI":"10.4103\/0971-5851.144991","article-title":"National cancer control and registration program in India","volume":"35","author":"Rath","year":"2014","journal-title":"Indian J Med Paediatr Oncol"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.semradonc.2016.11.007","article-title":"Radiation oncology in India: Challenges and opportunities","volume":"27","author":"Grover","year":"2017","journal-title":"Semin Radiat Oncol"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.ijrobp.2014.11.026","article-title":"A comparison of evidence-based estimates and empirical benchmarks of the appropriate rate of use of radiation therapy in Ontario","volume":"91","author":"Mackillop","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"R25-20260817","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(19)30794-6","article-title":"How public health services pay for radiotherapy in Europe: An ESTRO\u2013HERO analysis of reimbursement","volume":"21","author":"Lievens","year":"2020","journal-title":"Lancet Oncol"}],"container-title":["Journal of Cancer Research and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_812_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:01:40Z","timestamp":1786968100000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jcrt.jcrt_812_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/jcrt.jcrt_812_25","relation":{},"ISSN":["0973-1482","1998-4138"],"issn-type":[{"value":"0973-1482","type":"print"},{"value":"1998-4138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"2025-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-08","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}